Xiaoqin Li

Title: Innovations of Xiaoqin Li in Therapeutic Methods

Introduction

Xiaoqin Li is a prominent inventor based in Ann Arbor, MI, known for her significant contributions to the field of therapeutic methods. With a total of nine patents to her name, she has made remarkable strides in the development of innovative treatments for various diseases.

Latest Patents

Among her latest patents are the BET bromodomain inhibitors and therapeutic methods using the same. These patents disclose inhibitors of BET bromodomains and compositions containing these inhibitors. The methods outlined in her patents focus on using BET bromodomain inhibitors in the treatment of diseases where inhibition provides a therapeutic benefit, particularly in cancers. Additionally, she has developed compositions comprising thienopyrimidine and thienopyridine compounds, along with methods to inhibit the interaction of menin with MLL1, MLL2, and MLL-fusion oncoproteins.

Career Highlights

Xiaoqin Li is affiliated with the University of Michigan, where she continues to advance her research and innovation in therapeutic methods. Her work has garnered attention for its potential impact on cancer treatment and other medical applications.

Collaborations

Xiaoqin has collaborated with notable colleagues, including Duxin Sun and Shaomeng Wang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Xiaoqin Li's work exemplifies the intersection of innovation and therapeutic development, showcasing her commitment to improving health outcomes through her inventions. Her contributions to the field are invaluable and continue to inspire future advancements in medical research.